Clinical Trials Browser

Has announcements × Carcinoma, Merkel Cell × pembrolizumab × Clear all

NCT02267603 2023-07-05

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

Phase 2 Completed

50 enrolled 11 charts 1 FDA

Carcinoma, Merkel Cell